Scientech Research LLC ALNY β€” ALNYLAM PHARMACEUTICALS INC

Ownership history in Scientech Research LLC  Β·  4 quarters on record

AI Ownership Summary

Scientech Research LLC reported ALNYLAM PHARMACEUTICALS INC (ALNY) in 4 quarterly 13F filings from 2024 Q1 through 2025 Q4. Peak portfolio weight reached 0.62% in 2025 Q3. The latest visible filing shows ALNY at 0.17% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this ALNY ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Scientech Research LLC's position in ALNYLAM PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ALNY was reported at 0.17% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.62% in 2025 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

ALNY stock page Scientech Research LLC fund profile Scientech Research LLC full holdings
How Scientech Research LLC held ALNY β€” position size vs. price
% of Fund (quarterly)    ALNY price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
πŸ“‹ Quarterly Holdings History 4 quarters  β–Ύ
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 82.5% -16.8% βœ… 676 -3,196 -82.5% 0.17% $269K 2026-02-14 (Est.) $314.40
2025 Q3 ADDED β€” β€” β€” 3,872 +1,592 +69.8% 0.62% $1.8M 2025-11-14 $449.16
2024 Q4 REDUCED 15.2% +14.8% ❌ 2,280 -408 -15.2% 0.15% $537K 2025-02-14 $256.45
2024 Q1 INITIATED β€” β€” β€” 2,688 β€” β€” 0.21% $402K 2024-05-15 $147.40

🏒 Other funds also holding ALNY

As of 2026 Q1 β€” sorted by position size

Cannon Global Investment Management, LLC 3Y 1.55% SIERRA SUMMIT ADVISORS LLC 1.46% Bronte Capital Management Pty Ltd. 3Y 7Y 1.22% ANTIPODES PARTNERS Ltd 3Y 7Y 0.93% Privium Fund Management B.V. 3Y 0.84% Slow Capital, Inc. 3Y 7Y 0.75% Draper Asset Management, LLC 3Y 0.71% China Universal Asset Management Co., Ltd. 3Y 0.68% CONGRESS ASSET MANAGEMENT CO 3Y 7Y 0.68% Capstone Capital Management Ltd 0.59%

FAQ About Scientech Research LLC and ALNY

These are the practical questions this page is built to answer before you even open the full history table.

How long has Scientech Research LLC reported owning ALNY?

Scientech Research LLC reported ALNY across 4 quarterly 13F filings, from 2024 Q1 through 2025 Q4.

What was the largest reported ALNY position in Scientech Research LLC's portfolio?

The largest reported portfolio weight for ALNY was 0.62% in 2025 Q3.

What is the latest reported ALNY position on this page?

The most recent filing on this page is 2025 Q4, when Scientech Research LLC reported 676 shares, equal to 0.17% of portfolio, with an estimated market value of $269K.

What does the chart on this ALNY ownership page compare?

The chart compares Scientech Research LLC's quarterly ALNY portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Scientech Research LLC time their ALNY position?

Based on 13F filing dates vs. subsequent ALNY price moves, Scientech Research LLC correctly timed 1 out of 3 reported position changes (33%).

← Back to Scientech Research LLC Holdings